CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This trial studies the efficacy and safety of cryoablation in patients with low risk, early stage breast cancer. Cryoablation is a ...
Saint Louis, Missouri, United States
This trial is a Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with ER+/HER2- localized breast cancer...
Phase 2
Saint Louis, Missouri, United States and 48 other locations
to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...
Phase 2
Saint Louis, Missouri, United States and 10 other locations
The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy [paclitaxel] and ave ...
Phase 2
Saint Louis, Missouri, United States and 17 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Saint Louis, Missouri, United States and 226 other locations
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...
Phase 2
Saint Louis, Missouri, United States and 57 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Saint Louis, Missouri, United States and 114 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Saint Louis, Missouri, United States and 324 other locations
human epidermal receptor 2-negative (HER2)- palbociclib-resistant breast cancer, and to determine the recommended Phase 2 dose (RP2...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 5 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Saint Louis, Missouri, United States and 50 other locations
Clinical trials
Research sites
Resources
Legal